Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial
氟维司群联合凡德他尼与安慰剂治疗对芳香化酶抑制剂疗法 (FURVA) 耐药的转移性乳腺癌患者的疗效对比:一项多中心、第 2 期、随机对照试验
期刊:
影响因子:
doi:10.1038/s44276-023-00016-8
Mark Beresford, Angela Casbard, Zoe Hudson, Margherita Carucci, Kate Ingarfield, Julia Gee, Joanna Smith, Terri Kitson, Fouad Alchami, Tracie-Ann Madden, Larrie Hayward, David Hwang, Saiqa Spensley, Simon Waters, Duncan Wheatley, Robert H Jones